adventage thanks to technology
no lumps, no massaging
LENISNA is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L – lactide).
Thanks to the patented manufacturing technology, patent no. 10-1481441, no. 10-1725279, a preparation with unique properties has been created: long-lasting effectiveness and an increased safety profile.
LENISNA is designed as a time-acting filler with a concentration of 170 mg of PDLLA polylactic acid, and 30 mg of non-cross-linked hyaluronic acid. By adjusting the amount of the solution and the particle size from 50 to 60 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid was obtained that is suitable for application in subcutaneous or periosteal tissue.
It is intended for the treatment of deep wrinkles, laxity and significant tissue defects.
WOW EFFECT! Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we obtain an effect that is visible immediately after the treatment.
The filling is maintained until the production of new collagen, elastin, by polylactic acid begins to dominate.
- its ability to stimulate collagen production in the strongest possible way and restore youthful appearance in a gradual and natural way.
- no need to massage the post-treatment areas due to the round shape of PDLLA acid molecules and its combination with non-cross-linked hyaluronic acid.
- the durability of the treatment lasts over 24 months from the last treatment. The effect can be sustained by performing 1 reminder treatment after 24 months.
Due to the high concentration of poly D,L lactic acid – 170 mg and hyaluronic acid – 30 mg, the treatment is intended for people:
- with clear signs of aging 40 +
- needing to increase the volume of sunken areas of the face
- especially for the correction of skin depressions such as: folds in the skin, wrinkles, furrows, as well as in the case of face drooping and skin laxity
The effects of the therapy are visible immediately after administration. We obtain a filling effect thanks to the presence of hyaluronic acid. After about 2 weeks, the production of collagen is initiated by the presence of PDLLA lactic acid microparticles. The effects of the therapy last for over two years after the last treatment. The recommended number of treatments is 2 or 3, depending on the skin deficiency, at intervals of 6-8 weeks. After two years it is recommended to carry out 1 reminder treatment.
- the preparation in the amount of 5 ml is administered with the use of a thin cannula of 22 to 25 G size or needles of 25-26 G size
- it is applied to the subcutaneous or periosteal tissue
how lenisna works?
1. PHYSICAL SUPPORT
DAY 1.
2. RESTORATION
after 1 month
3. maintenance
6. month
stages of the treatment
Mixing of the preparation
Add 5 ml of sterile water for injection to the vial. Place the preparation in a VORTEX laboratory shaker. After 30 minutes, the preparation is ready for use.
anesthesia
In the case of injection of the preparation with a cannula, a specialist performs anesthesia of the injection site
performance of the treatment
Performing the procedure with a needle or cannula
differences in lactic acid
in the form of PDLLA and regular PLLA
vs
vs
Features and benefits of using Lenisna
- the only hybrid formula in the world Poly D, L Lactide + HA with particle size from 50 to 60 micrometers
- effectiveness and safety confirmed by clinical trials
- durability of effects – over 2 years from the last treatment
- immediate effect – due to hyaluronic acid
- safety – FDA and CE certificates for polylactic acid
- patents and own clinical trials
- particle size from 50 to 60 microns
- comfort of the procedure – easy injection and no needle clogging during the procedure
testimonials
